Ultragenyx Pharmaceutical | RARE - Pre Tax Profit

Stock Price
24.65
Daily Change
0.86 3.62%
Monthly
1.86%
Yearly
-45.65%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $-179.54M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Insmed USD -368.7M 48.26M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Kyowa Hakko Kirin JPY 25.95B 11.83B Sep/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Moderna USD -187M 631M Sep/2025
Neurocrine Biosciences USD 291.8M 132.3M Sep/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025